Thaler S - Search Results

1

An in vivo evaluation of Brilliant Blue G in animals and humans.

Remy M, Thaler S, Schumann RG, May CA, Fiedorowicz M, Schuettauf F, Grüterich M, Priglinger SG, Nentwich MM, Kampik A, Haritoglou C. Remy M, et al. Among authors: thaler s. Br J Ophthalmol. 2008 Aug;92(8):1142-7. doi: 10.1136/bjo.2008.138164. Br J Ophthalmol. 2008. PMID: 18653608 Free article. Clinical Trial.

2

Staining and peeling of the internal limiting membrane using a fluorescent dye (Rhodamine 6 G).

Haritoglou C, Kreutzer T, Tadayoni R, Langhals H, May CA, Thaler S, Kampik A. Haritoglou C, et al. Among authors: thaler s. Br J Ophthalmol. 2008 Sep;92(9):1265-8. doi: 10.1136/bjo.2008.141911. Epub 2008 Jun 27. Br J Ophthalmol. 2008. PMID: 18586900 Free article.

3

In vivo biocompatibility of a new cyanine dye for ILM peeling.

Thaler S, Haritoglou C, Schuettauf F, Choragiewicz T, May CA, Gekeler F, Fischer MD, Langhals H, Schatz A. Thaler S, et al. Eye (Lond). 2015 Mar;29(3):428-35. doi: 10.1038/eye.2014.295. Epub 2014 Dec 19. Eye (Lond). 2015. PMID: 25523205 Free PMC article.

4

In vivo toxicity study of rhodamine 6G in the rat retina.

Thaler S, Haritoglou C, Choragiewicz TJ, Messias A, Baryluk A, May CA, Rejdak R, Fiedorowicz M, Zrenner E, Schuettauf F. Thaler S, et al. Invest Ophthalmol Vis Sci. 2008 May;49(5):2120-6. doi: 10.1167/iovs.07-1476. Invest Ophthalmol Vis Sci. 2008. PMID: 18436844

5

In vivo toxicity testing of methyl blue and aniline blue as vital dyes for intraocular surgery.

Thaler S, Schuettauf F, Fiedorowicz M, Messias A, Schatz A, Choragiewicz TJ, May CA, Zrenner E, Kampik A, Haritoglou C. Thaler S, et al. Retina. 2009 Oct;29(9):1257-65. doi: 10.1097/IAE.0b013e3181b8615b. Retina. 2009. PMID: 19934820

6

Experimental evaluation of aniline and methyl blue for intraocular surgery.

Haritoglou C, Priglinger S, Liegl R, May CA, Eibl K, Thaler S, Kampik A, Schuettauf F. Haritoglou C, et al. Among authors: thaler s. Retina. 2009 Oct;29(9):1266-73. doi: 10.1097/IAE.0b013e3181b8626f. Retina. 2009. PMID: 19934821

7

[Vital dyes in vitreoretinal surgery. Current application concepts].

Haritoglou C, Thaler S, Kampik A, Schüttauf F. Haritoglou C, et al. Among authors: thaler s. Ophthalmologe. 2009 Jan;106(1):7-10. doi: 10.1007/s00347-008-1853-5. Ophthalmologe. 2009. PMID: 19082605 Review. German.

8

Toxicity study of erucylphosphocholine in a rat model.

Schuettauf F, Eibl KH, Thaler S, Shinoda K, Rejdak R, May CA, Blatsios G, Welge-Lussen U. Schuettauf F, et al. Among authors: thaler s. Curr Eye Res. 2005 Sep;30(9):813-20. doi: 10.1080/02713680591006093. Curr Eye Res. 2005. PMID: 16146926

9

Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.

Schuettauf F, Haritoglou C, May CA, Rejdak R, Mankowska A, Freyer W, Eibl K, Zrenner E, Kampik A, Thaler S. Schuettauf F, et al. Among authors: thaler s. Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3573-8. doi: 10.1167/iovs.06-0211. Invest Ophthalmol Vis Sci. 2006. PMID: 16877431

10

An experimental approach towards novel dyes for intraocular surgery.

Haritoglou C, Schüttauf F, Gandorfer A, Thaler S. Haritoglou C, et al. Among authors: thaler s. Dev Ophthalmol. 2008;42:141-152. doi: 10.1159/000139003. Dev Ophthalmol. 2008. PMID: 18535387 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page